iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/26808232/
Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun;144(8):1652-60.
doi: 10.1017/S0950268816000054. Epub 2016 Jan 25.

Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control

A A Chughtai  1 , M Barnes  1 , C R Macintyre  1
Affiliations
Review

Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control

A A Chughtai et al. Epidemiol Infect. 2016 Jun.

Abstract

The aim of this study was to review the current evidence regarding the persistence of Ebola virus (EBOV) in various body fluids during convalescence and discuss its implication on disease transmission and control. We conducted a systematic review and searched articles from Medline and EMBASE using key words. We included studies that examined the persistence of EBOV in various body fluids during the convalescent phase. Twelve studies examined the persistence of EBOV in body fluids, with around 800 specimens tested in total. Available evidence suggests that EBOV can persist in some body fluids after clinical recovery and clearance of virus from the blood. EBOV has been isolated from semen, aqueous humor, urine and breast milk 82, 63, 26 and 15 days after onset of illness, respectively. Viral RNA has been detectable in semen (day 272), aqueous humor (day 63), sweat (day 40), urine (day 30), vaginal secretions (day 33), conjunctival fluid (day 22), faeces (day 19) and breast milk (day 17). Given high case fatality and uncertainties around the transmission characteristics, patients should be considered potentially infectious for a period of time after immediate clinical recovery. Patients and their immediate contacts should be informed about these risks. Convalescent patients may need to abstain from sex for at least 9 months or should use condoms until their semen tests are negative. Breastfeeding should be avoided during the convalescent phase. There is a need for more research on persistence, and a uniform approach to infection control guidelines in convalescence.

Keywords: Body fluids; Ebola virus; transmission.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Search strategy and selection of papers.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. World Health Organisation (WHO). Global alert and response (GAR). Ebola situation reports (http://www.who.int/csr/disease/ebola/situation-reports/en/). Accessed 5 October 2015.
    1. Francesconi P, et al. Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerging Infectious Diseases 2003; 9: 1430–1437. - PMC - PubMed
    1. MacIntyre CR, et al. Respiratory protection for healthcare workers treating Ebola virus disease (EVD): are facemasks sufficient to meet occupational health and safety obligations? International Journal of Nursing Studies 2014; 51: 1421–1426. - PMC - PubMed
    1. Rodriguez LL, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. Journal of Infectious Diseases 1999; 179 (Suppl. 1): S170–176. - PubMed
    1. Kreuels B, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. New England Journal of Medicine 2014; 371: 2394–2401. - PubMed